CBT
ABBV icon

Capital Bank & Trust’s AbbVie ABBV Stock Holding History

Capital Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50,239
Closed -$5.44M – 205
2021
Q1 		$5.44M Buy
50,239
+955
+2% +$102K 0.06% 156
2020
Q4 		$5.28M Buy
49,284
+6,032
+14% +$580K 0.06% 147
2020
Q3 		$3.79M Sell
43,252
-2,664
-6% -$251K 0.05% 152
2020
Q2 		$4.51M Sell
45,916
-67
-0.1% -$5.9K 0.07% 144
2020
Q1 		$3.5M Sell
45,983
-4
-0% -$341 0.06% 144
2019
Q4 		$4.07M Sell
45,987
-428
-0.9% -$35.5K 0.05% 148
2019
Q3 		$3.52M Sell
46,415
-225
-0.5% -$15.4K 0.05% 149
2019
Q2 		$3.39M Buy
46,640
+8,457
+22% +$665K 0.04% 165
2019
Q1 		$3.08M Sell
38,183
-7,669
-17% -$627K 0.04% 165
2018
Q4 		$4.23M Buy
45,852
+143
+0.3% +$12.6K 0.06% 145
2018
Q3 		$4.32M Sell
45,709
-47
-0.1% -$4.46K 0.05% 145
2018
Q2 		$4.24M Buy
45,756
+31,162
+214% +$3.04M 0.06% 148
2018
Q1 		$1.38M Sell
14,594
-75
-0.5% -$8.24K 0.02% 172
2017
Q4 		$1.42M Buy
14,669
+1,575
+12% +$148K 0.02% 176
2017
Q3 		$1.16M Buy
13,094
+2,456
+23% +$187K 0.01% 172
2017
Q2 		$771K Buy
+10,638
New +$715K 0.01% 186

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Capital Bank & Trust's ABBV Position: Q2 2021 in Review

Capital Bank & Trust sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 50,239 shares — an estimated $5.44M sold.

Capital Bank & Trust first reported a position in ABBV in Q2 2017 and held it in 16 quarters. The position peaked at $5.44M in Q1 2021. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Capital Bank & Trust reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
  • Capital Bank & Trust sold 50,239 AbbVie shares in Q2 2021, an estimated $5.44M.
  • Capital Bank & Trust first reported a position in AbbVie in Q2 2017 and held it in 16 quarters.
  • Capital Bank & Trust's AbbVie position peaked at $5.44M in Q1 2021.
  • 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Capital Bank & Trust's 13F filing for Q2 2021, filed 16 Aug 2021.